We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.36B
AUM Growth
-$1.68B
Cap. Flow
-$1.45B
Cap. Flow %
-43.28%
Top 10 Hldgs %
28.65%
Holding
6,080
New
399
Increased
1,937
Reduced
2,718
Closed
947

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$126M
2
NVDA icon
NVIDIA
NVDA
+$101M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$97.8M
4
MSFT icon
Microsoft
MSFT
+$89.5M
5
AMZN icon
Amazon
AMZN
+$44.3M

Sector Composition

Rank Sector Weight
1 Technology 19.97%
2 Financials 9.87%
3 Consumer Discretionary 8.34%
4 Healthcare 7.98%
5 Communication Services 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYEL icon
3401
Lyell Immunopharma
LYEL
$342M
$13.1K ﹤0.01%
1,213
+238
+24% +$2.92K
INGN icon
3402
Inogen
INGN
$153M
$13.1K ﹤0.01%
1,831
+227
+14% +$2.14K
MSTX
3403
Defiance Daily Target 2x Long MSTR ETF
MSTX
$126M
$13.1K ﹤0.01%
51
+28
+122% +$10.6K
CRSR icon
3404
Corsair Gaming
CRSR
$1.41B
$13K ﹤0.01%
1,497
-258
-15% -$2.54K
AMTX icon
3405
Aemetis
AMTX
$128M
$13K ﹤0.01%
7,488
-2,919
-28% -$6.24K
CLOZ icon
3406
Panagram BBB-B CLO ETF
CLOZ
$806M
$13K ﹤0.01%
+490
New +$13.2K
DNB
3407
DELISTED
Dun & Bradstreet
DNB
$13K ﹤0.01%
1,454
-6,263
-81% -$64.1K
GLP icon
3408
Global Partners
GLP
$1.72B
$13K ﹤0.01%
243
-256
-51% -$13.8K
TNYA icon
3409
Tenaya Therapeutics
TNYA
$163M
$13K ﹤0.01%
22,730
+10,328
+83% +$10.2K
PINC
3410
DELISTED
Premier
PINC
$13K ﹤0.01%
672
+483
+256% +$9.51K
LXRX icon
3411
Lexicon Pharmaceuticals
LXRX
$1.03B
$13K ﹤0.01%
28,107
+15,952
+131% +$10.1K
BBD icon
3412
Banco Bradesco
BBD
$34.2B
$12.9K ﹤0.01%
5,778
-109,444
-95% -$227K
SMHI icon
3413
SEACOR Marine Holdings
SMHI
$268M
$12.9K ﹤0.01%
2,556
-1,305
-34% -$8.06K
QTRX icon
3414
Quanterix
QTRX
$122M
$12.9K ﹤0.01%
1,984
-3,718
-65% -$31K
MGX icon
3415
Metagenomi Therapeutics
MGX
$46.5M
$12.9K ﹤0.01%
9,495
+5,623
+145% +$13.4K
KROS icon
3416
Keros Therapeutics
KROS
$200M
$12.9K ﹤0.01%
1,265
-21,719
-94% -$252K
EMB icon
3417
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$12.9K ﹤0.01%
142
+112
+373% +$10.1K
BRT
3418
BRT Apartments
BRT
$270M
$12.9K ﹤0.01%
756
-989
-57% -$17.5K
UVE icon
3419
Universal Insurance Holdings
UVE
$1.2B
$12.8K ﹤0.01%
542
-212
-28% -$4.37K
ACIU icon
3420
AC Immune
ACIU
$248M
$12.8K ﹤0.01%
6,864
-49
-0.7% -$123
TBCH
3421
Turtle Beach Corp
TBCH
$228M
$12.8K ﹤0.01%
901
+85
+10% +$1.42K
SFD
3422
Smithfield Foods
SFD
$8.96B
$12.8K ﹤0.01%
+628
New +$12.8K
FSBW icon
3423
FS Bancorp
FSBW
$323M
$12.8K ﹤0.01%
336
-690
-67% -$27K
LFCR icon
3424
Lifecore Biomedical
LFCR
$179M
$12.8K ﹤0.01%
1,813
+367
+25% +$2.28K
LZM icon
3425
Lifezone Metals
LZM
$356M
$12.7K ﹤0.01%
3,045
+1,034
+51% +$5.78K

Similar funds

Tower Research Capital (TRC)'s Q1 2025 Portfolio in Review

As of Q1 2025, Tower Research Capital (TRC) held 6,080 positions worth $3.36B, down 33% from $5.04B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.45B in Q1 2025, closing 947 positions and reducing 2,718 holdings. Its most notable exit was Listed Funds Trust Roundhill Magnificent Seven ETF, an estimated $8.86M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $18.3M.

  • Tower Research Capital (TRC)'s largest Q1 2025 buy was Vanguard S&P 500 ETF: 35,404 shares worth $18.3M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2025, an estimated $274M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2025 reduction was Apple, cutting an estimated $126M.
  • Tower Research Capital (TRC) fully exited Listed Funds Trust Roundhill Magnificent Seven ETF in Q1 2025, selling an estimated $8.86M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3.36B portfolio in Q1 2025.
  • Tower Research Capital (TRC) opened 399 new positions and closed 947 in Q1 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 33% quarter-over-quarter to $3.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.